Skip to main content
Fig. 2 | Trials

Fig. 2

From: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial

Fig. 2

Study timeline. Clinical examination includes visual acuity measurement, Goldmann applanation tonometry (GAT), and slit-lamp biomicroscopy of the anterior and posterior segments. OCT optical coherence tomography, RNFL retinal nerve fiber layer, GCIPL ganglion cell inner plexiform layer, GPA Guided Progression Analysis, TPA Trend-based Progression Analysis, VF visual field

Back to article page